期刊文献+

转化生长因子-β_2(TGF-β_2)诱导人视网膜色素上皮层细胞上皮-间质转分化中miRNA-29b的表达及意义 被引量:4

Expression changes and significance of miRNA-29b in TGF-β_2 induced epithelial mesenchymal transition of human retinal pigment epithelial cells
下载PDF
导出
摘要 目的探究转化生长因子-β2(transforming growth factor-β2,TGF-β2)诱导人视网膜色素上皮(retinal pigment epithelial,RPE)层细胞上皮-间质转分化中miRNA-29b的表达变化及意义。方法使用不同浓度TGF-β2刺激RPE细胞上皮-间质转分化后,倒置相差显微镜观察细胞形态变化,Western blot、RT-PCR检测成纤维化相关分子纤维连接蛋白(fibronection,FN)、神经钙粘连蛋白(nerve calcium adhesion protein,N-Cadherin)的表达。采用RT-PCR检测不同浓度TGF-β2及不同时间TGF-β2(5μg·L^(-1))刺激RPE细胞后miRNA-29b的表达。结果 TGF-β2刺激后的RPE细胞形态呈纤维化改变。在一定浓度范围内(1μg·L^(-1)、5μg·L^(-1)、10μg·L^(-1)),随着TGF-β2浓度的增加FN、N-Cadherin及相应mRNA随之增加,1μg·L^(-1)、5μg·L^(-1)、10μg·L^(-1)组与对照组(0μg·L^(-1))相比,差异均有统计学意义(均为P<0.01)。TGF-β2在一定浓度范围内(0μg·L^(-1)、1μg·L^(-1)、5μg·L^(-1))以剂量依赖的方式诱导RPE细胞miRNA-29b表达的降低,1μg·L^(-1)、5μg·L^(-1)、10μg·L^(-1)组与对照组(0μg·L^(-1))相比,差异均有统计学意义(均为P<0.01),在TGF-β2浓度为5μg·L^(-1)时miRNA-29b表达量最低。TGF-β2在一定时间范围内(0 h、3 h、6 h、12 h)以时间依赖的方式诱导RPE细胞miRNA-29b表达的降低,3 h、6 h、12 h、24 h、48 h组与0 h相比差异均有统计学意义(均为P<0.05)。结论一定范围内TGF-β2以剂量和时间依赖的方式诱导RPE细胞miRNA-29b的表达,为进一步研究miRNA-29b与TGF-β2在RPE细胞上皮-间质转分化过程中的相互作用提供理论基础。 Objective To explore the expression changes and significance of miRNA-29b in TGF-β2 induced epithelial mesenchymal transition (EMT) of human retinal pigment epithelial (RPE) cells. Methods Different concentrations of TGF-β2 (0 μg · L^-1 ,1 μg · L^-1,5 μg · L^-1 ,10μg · L^-1) were used to stimulate EMT of RPE ceils, and then the changes of cell morphology were observed by in- verted phase contrast microscope. The expression of fibronectin (FN) and nerve calcium adhesion protein (N-Cadherin) were detected by Western blot and RT- PCR. RT-PCR was used to detect the expression of miRNA-29b in RPE cells after stimulated with TGF-β2 at different concentrations(0μg · L^-1, 1 μg · L^-1 ,5 μg · L^-1 ,10μg · L^-1) and at different time points (0 hour,3 hours,5 hours,12 hours, 24 hours,48 hours) of TGF-β2 (5 μg · L^-1 ). Results RPE cells exhibited a fiber-like morphology after stimulated with TGF-β2. With the increase of TGF-β2 concentration (1μg · L^-1 ,5 μg · L^-1 ,10 μg · L^-1) and the expression of FN,N- Cadherin protein and the corresponding mRNA increased. Other groups ( 1 μg · L^-1 ,5 μg · L^-1, 10 μg · L^-1 ) compared with blank control group (0 μg · L^-1), the differences were significant ( all P 〈 0. 01 ). RPE cells induced by TGF-β2 showed a decreasing expression of miRNA-29b in a dose dependent manner (0 μg · L^-1,1μg · L^-1,5 μg · L^-1). Other groups (1μg · L^-1,5μg · L^-1, 10 μg · L^-1 ) compared with blank control group (0 μg · L^-1 ) and the differences were significant ( all P 〈0.01 ). When the TGF-β2 concentration was 5 μg · L^-1, the expression of miRNA-29b reached the lowest. RPE cells induced by TGF-β2 showed a decreasing expression of miRNA-29b in a time dependent manner (0 hour,3 hours,6 hours, 12 hours). Other groups (3 hours,6 hours, 12 hours,24 hours,48 hours) compared with blank control group (0 hour) and the differences were significant ( all P 〈 0.05 ). Conclusion TGF-β2 can induce the expression of miRNA-29b in RPE cells in a time and dose-dependent manner in a certain range,which provide a theoretical basis for the further study of the cross-talk miRNA-29b and TGF-β2 in the EMT process of RPE cells.
出处 《眼科新进展》 CAS 北大核心 2016年第11期1001-1005,共5页 Recent Advances in Ophthalmology
基金 国家自然科学基金面上项目(编号:81270979)~~
关键词 人视网膜色素上皮层细胞 上皮-间质转分化 转化生长因子-Β2 miRNA-29b 增生性玻璃体视网膜病变 human retinal pigment epithelial cells epithelial mesenchymal transition transforming growth factor β2 miRNA-29b proliferative vitreoretinopathy
  • 相关文献

参考文献24

  • 1YANG S,U H,U M, WANG F. Mechanisms of epitheUal-mes-enchymal transition in proliferative vitreoretmopathy [ J ].Discov Merf,2015,20( 110) :207-217.
  • 2KWON OW,SONG JH,ROH MI. Retinal detachment and pro-liferative vitreoretmopathy [ J]. Dev Ophthalmol, 2016,55 :154-162.
  • 3FRIEDLANDER M. Fibrosis and diseases of the eye[ J]. JClin /nuesi,2007,117(3) :576-586.
  • 4PASTOR JC,DE LA RUA ER,MARTIN F. Proliferative vitreo-retinopathy:risk factors and pathobiology [ J ]. Prog RetinEyeRes,2(m,21(1) : 127-144.
  • 5BARTEL DP. MicroRNAs : genomics, biogenesis, mechanism,and function[J].Ce?,2004,116(2) :281-297.
  • 6HE Y,HUANG C,UN X,LJ J. MicroRNA-29 family,a crucialtherapeutic target for fibrosis diseases [ J ]. Biochimie, 2013,95(7) :1355.
  • 7IOTA T,HATA Y,ARITA R,KAWAHARA S,MIURA M,NA-KAO S,et al. Role of TGF-beta in proliferative vitxeoretinaldiseases and ROCK as a therapeutic target [ J]. Proc NatlAcadSd USA ,2008,105 (45) : 17504-17509.
  • 8IOTA T,HATA Y,KANO K,MIURA M,NAKAO S,NODAY,付al. Transforniing growth factor-beta2 and connective tissuegrowth factor in proliferative vitreoretinal diseases : possibleinvolvement of hyalocytes and therapeutic potential of Rhokinase inhibitor[ J]. Diabetes ,2007,56 (1) :231-238.
  • 9BORDER WA,NOBLE NA. Transforming growth factor betain tissue fibrosis [ J]. N Engl J Med, 1994, 331 ( 19) : 1286-1292.
  • 10AKHURST RJ,HATA A. Targeting the TGF beta signalling path-way in disease[ J].Nat Rev Drug Discov,2012,11 (10) :790-811.

同被引文献48

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部